Erschienen in:
01.05.2013 | Case Report
Favorable outcome in a child with EBV-negative aggressive NK cell leukemia
verfasst von:
Jeong A. Park, Kyung Ran Jun, So Hyun Nam, Thad T. Ghim
Erschienen in:
International Journal of Hematology
|
Ausgabe 5/2013
Einloggen, um Zugang zu erhalten
Abstract
Aggressive natural killer cell leukemia (ANKL) is a rare malignant disorder of mature NK cells frequently associated with Epstein–Barr virus (EBV). This malignancy is typically treated with intensive remission induction chemotherapy followed by allogeneic hematopoietic stem cell transplantation (HSCT). EBV-negative ANKL and childhood ANKL, however, are not well defined and the optimal therapeutic strategy in these cases is poorly understood. Here, we present a unique pediatric EBV-negative ANKL patient who achieved a successful treatment outcome after intensified ALL type chemotherapy without allogeneic HSCT.